Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
$IKT Found an interesting article | jedijazz | investorshub | 04/17/2023 8:00:23 AM |
$IKT Looks pretty positive | conix | investorshub | 04/16/2023 10:45:21 PM |
$IKT MomentumIts trading | jedijazz | investorshub | 04/16/2023 7:11:57 PM |
$IKT Lets go go go go... Up up and away we go. | conix | investorshub | 04/16/2023 6:05:34 PM |
$IKT short data if anyone is interested | conix | investorshub | 04/16/2023 4:37:01 AM |
The now | heyitsmeagain | investorshub | 04/16/2023 3:16:07 AM |
$IKT MomentumIts trading | estreet7883 | investorshub | 04/16/2023 12:21:40 AM |
$IKT MomentumIts now up | conix | investorshub | 04/15/2023 9:17:46 PM |
MomentumIts trading up | PennyPusher786 | investorshub | 04/15/2023 4:53:59 PM |
MomentumIts now up | conix | investorshub | 04/15/2023 1:55:22 PM |
where is the squeeze? | ProfitScout | investorshub | 04/15/2023 12:38:03 PM |
$IKT What do you make of this? | conix | investorshub | 04/15/2023 9:46:57 AM |
$IKT The now up | INFINITI | investorshub | 04/15/2023 9:36:01 AM |
$IKT Price trading last up | conix | investorshub | 04/15/2023 9:26:58 AM |
$IKT MomentumIts trading | jedijazz | investorshub | 04/15/2023 4:48:25 AM |
$IKT MomentumIts trading up | conix | investorshub | 04/15/2023 2:25:47 AM |
Thoughts on where this is headed? | conix | investorshub | 04/15/2023 1:13:10 AM |
$IKT MomentumIts trading | conix | investorshub | 04/15/2023 12:32:45 AM |
$IKT short squeeze all day | conix | investorshub | 04/14/2023 9:48:54 PM |
MomentumIts trading up | conix | investorshub | 04/14/2023 8:29:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...